NCT04186052View on ClinicalTrials.gov

Clinical Trial of BCMA CAR T Cell Infusion in Patients With BCMA-positive r/r Multiple Myeloma

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 8, 2019

Primary Completion Date

March 1, 2021

Study Completion Date

March 1, 2021

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

BCMA-CART cells

Target BCMA chimeric antigen receptor T cell infusion

Trial Locations (1)

Unknown

RECRUITING

Hematology Department of the Second Affiliated Hospital of Suzhou University, Suzhou

Sponsors
All Listed Sponsors
collaborator

Second Affiliated Hospital of Suzhou University

OTHER

lead

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

INDUSTRY